Solux Co. Ltd Market Cap ($121.02 Million)
Market Cap & Net Worth: Solux Co. Ltd (290690)
Solux Co. Ltd market cap. Solux Co. Ltd (KQ:290690) has a market capitalization of $121.02 Million (₩178.58 Billion) as of November 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #18289 globally and #805 in its home market, demonstrating a 32.36% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Solux Co. Ltd's stock price ₩3620.00 by its total outstanding shares 49332512 (49.33 Million). Also see 290690 operating cash flow for how efficiently the company converts equity into cash flow.
Solux Co. Ltd Market Cap History (2020–2026)
Solux Co. Ltd market cap history from 2020 to 2026. Data shows change from $205.73 Million to $121.02 Million (-13.01% CAGR). Check 290690 live share price for real-time trading data and today's change.
Index Memberships
Solux Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$207.23 Billion | 0.06% | #301 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$207.23 Billion | 0.06% | #301 of 1384 |
Weight: Solux Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Solux Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Solux Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Solux Co. Ltd growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
Solux Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $205.73 Million | $57.63 Billion | $4.45 Billion | 0.00x | 0.05x |
| 2021 | $110.42 Million | $70.01 Billion | $4.16 Billion | 0.00x | 0.03x |
| 2022 | $69.82 Million | $55.90 Billion | -$4.33 Billion | 0.00x | N/A |
| 2023 | $671.15 Million | $59.83 Billion | -$6.70 Billion | 0.01x | N/A |
| 2024 | $279.16 Million | $50.69 Billion | -$40.97 Billion | 0.01x | N/A |
| 2025 | $152.45 Million | $38.27 Billion | -$7.72 Billion | 0.00x | N/A |
Competitor Companies of 290690 by Market Capitalization
Companies near Solux Co. Ltd in the global market cap rankings as of November 5, 2026. Also see Solux Co. Ltd (290690) total assets for a full breakdown of the balance sheet.
Key companies related to Solux Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Solux Co. Ltd (2020–2026)
Market capitalization of Solux Co. Ltd from 2020 to today. Between 2020 and today, Solux Co. Ltd's market cap moved from $205.73 Million to $ 121.02 Million, with a yearly change of -13.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩121.02 Million | -20.61% |
| 2025 | ₩152.45 Million | -45.39% |
| 2024 | ₩279.16 Million | -58.41% |
| 2023 | ₩671.15 Million | +861.22% |
| 2022 | ₩69.82 Million | -36.77% |
| 2021 | ₩110.42 Million | -46.33% |
| 2020 | ₩205.73 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Solux Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $121.02 Million USD |
| MoneyControl | $121.02 Million USD |
| MarketWatch | $121.02 Million USD |
| marketcap.company | $121.02 Million USD |
| Reuters | $121.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Solux Co. Ltd
ARIBIO Holdings Inc. manufactures and supplies indoor, outdoor, and special purpose lighting products in South Korea and internationally. The company was formerly known as Solux Co., Ltd. and changed its name to ARIBIO Holdings Inc. in July 2026. ARIBIO Holdings Inc. was founded in 1995 and is headquartered in Gongju-si, South Korea.